NICI Quick Take

Willow Biosciences is a Canadian based , research and development company. It will focus on creating synthetic biology solution from gene discovery to cannabinoid commercialization.

The Company was formed from a business combination between Makena Resources, Biocan Technologies, Inc., and Epimeron, Inc. From the business combination, Willow has a pharmaceutical management team with extensive experience.

IPO Details

Valuation $46.2M
Total Raised $15.0M
NICI Subsector N/A
Website N/A